Brief: Initiator Pharma Q4 EBIT Loss Stable at DKK 2.5 Mln
Feb 21 (Reuters) - Initiator Pharma A/S INIT.TE :
* INITIATOR PHARMA: YEAR END REPORT 2019
* Q4 EBIT WAS TDKK -2,503 (-2,508)
Source text for Eikon: ID:nWkrcbwHN5
Further company coverage: INIT.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD